Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia

NCT07151612 is registered in ClinicalTrials.gov with Shanxi Eye Hospital as lead sponsor.

NCT NCT07151612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07151612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia
Lead sponsor
Shanxi Eye Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 4, 2025
Completion date
October 10, 2025
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia